PerkinElmer Inc
NYSE:PKI
PerkinElmer Inc
NYSE:PKI
Price:
114.21 USD
-0.89%
Updated:
May 7, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of PKI.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PKI
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
PKI Competitors Multiples
PerkinElmer Inc Competitors
PerkinElmer Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
PerkinElmer Inc
NYSE:PKI
|
14.4B USD | 3.2 | 19.3 | 11.9 | 16.7 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.3B USD | 5.2 | 37 | 22.8 | 33.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
183.1B USD | 4.2 | 22.7 | 16.5 | 20.3 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
55.9T KRW | 15.1 | 65.1 | 34.3 | 49.5 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
37.6B CHF | 5.6 | 57.5 | 19.8 | 29 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
41.7B USD | 2.8 | 30.5 | 16.7 | 25.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
41.1B USD | 6.1 | 33.5 | 26.5 | 31.9 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
26.7B USD | 7.1 | 33.9 | 23.7 | 26.3 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26.7B USD | 9.1 | 47 | 32.6 | 39.6 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
25.8B USD | 3.1 | 37.8 | 17.1 | 26.2 | |
| FR |
|
Sartorius Stedim Biotech SA
PAR:DIM
|
19.1B EUR | 7.1 | 75.3 | 32.2 | 52.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
